Cargando…
Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
INTRODUCTION: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258049/ https://www.ncbi.nlm.nih.gov/pubmed/35787743 http://dx.doi.org/10.1080/17482631.2022.2094111 |
_version_ | 1784741453690306560 |
---|---|
author | Russell, Cayley Pang, Michelle Nafeh, Frishta Farrell Macdonald, Shanna Derkzen, Dena Rehm, Jürgen Fischer, Benedikt |
author_facet | Russell, Cayley Pang, Michelle Nafeh, Frishta Farrell Macdonald, Shanna Derkzen, Dena Rehm, Jürgen Fischer, Benedikt |
author_sort | Russell, Cayley |
collection | PubMed |
description | INTRODUCTION: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada. METHODS: This article describes results from a longitudinal mixed-methods study examining OAT transition experiences among thirty-five individuals released from federal incarceration in Ontario, Canada. Assessments were completed within one year of participants’ release. Data were thematically analyzed. RESULTS: The majority (77%) of participants remained engaged in OAT, however, 69% had their release suspended and 49% returned to custody. Key facilitators for OAT engagement included flexibility, positive staff rapport, and structure. Fragmented OAT transitions, financial OAT coverage, balancing reintegration requirements, logistical challenges, and inaccessibility of ‘take-home’ OAT medications were common barriers. CONCLUSIONS: Post-incarceration transition periods are critical for OAT retention, yet individuals in Ontario experience barriers to OAT engagement that contribute to treatment disruptions and related risks such as relapse and/or re-incarceration. Additional measures to support community OAT transitions are required, including improved discharge planning, amendments to OAT and financial coverage policies, and an expansion of OAT options. |
format | Online Article Text |
id | pubmed-9258049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-92580492022-07-07 Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada Russell, Cayley Pang, Michelle Nafeh, Frishta Farrell Macdonald, Shanna Derkzen, Dena Rehm, Jürgen Fischer, Benedikt Int J Qual Stud Health Well-being Article INTRODUCTION: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada. METHODS: This article describes results from a longitudinal mixed-methods study examining OAT transition experiences among thirty-five individuals released from federal incarceration in Ontario, Canada. Assessments were completed within one year of participants’ release. Data were thematically analyzed. RESULTS: The majority (77%) of participants remained engaged in OAT, however, 69% had their release suspended and 49% returned to custody. Key facilitators for OAT engagement included flexibility, positive staff rapport, and structure. Fragmented OAT transitions, financial OAT coverage, balancing reintegration requirements, logistical challenges, and inaccessibility of ‘take-home’ OAT medications were common barriers. CONCLUSIONS: Post-incarceration transition periods are critical for OAT retention, yet individuals in Ontario experience barriers to OAT engagement that contribute to treatment disruptions and related risks such as relapse and/or re-incarceration. Additional measures to support community OAT transitions are required, including improved discharge planning, amendments to OAT and financial coverage policies, and an expansion of OAT options. Taylor & Francis 2022-07-05 /pmc/articles/PMC9258049/ /pubmed/35787743 http://dx.doi.org/10.1080/17482631.2022.2094111 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Article Russell, Cayley Pang, Michelle Nafeh, Frishta Farrell Macdonald, Shanna Derkzen, Dena Rehm, Jürgen Fischer, Benedikt Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada |
title | Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada |
title_full | Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada |
title_fullStr | Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada |
title_full_unstemmed | Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada |
title_short | Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada |
title_sort | barriers and facilitators to opioid agonist treatment (oat) engagement among individuals released from federal incarceration into the community in ontario, canada |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258049/ https://www.ncbi.nlm.nih.gov/pubmed/35787743 http://dx.doi.org/10.1080/17482631.2022.2094111 |
work_keys_str_mv | AT russellcayley barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada AT pangmichelle barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada AT nafehfrishta barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada AT farrellmacdonaldshanna barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada AT derkzendena barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada AT rehmjurgen barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada AT fischerbenedikt barriersandfacilitatorstoopioidagonisttreatmentoatengagementamongindividualsreleasedfromfederalincarcerationintothecommunityinontariocanada |